These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25935931)

  • 21. Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.
    Zhang M; Emerson SU; Nguyen H; Engle R; Govindarajan S; Blackwelder WC; Gerin J; Purcell RH
    Vaccine; 2002 Sep; 20(27-28):3285-91. PubMed ID: 12213398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis E: a neglected threat.
    Myint KS; Gibbons RV
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):211-2. PubMed ID: 17658568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HEV and transfusion-recipient risk.
    Izopet J; Lhomme S; Chapuy-Regaud S; Mansuy JM; Kamar N; Abravanel F
    Transfus Clin Biol; 2017 Sep; 24(3):176-181. PubMed ID: 28690036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.
    Arankalle VA; Chadha MS; Dama BM; Tsarev SA; Purcell RH; Banerjee K
    J Viral Hepat; 1998 May; 5(3):199-204. PubMed ID: 9658374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of hepatitis E: current status.
    Aggarwal R; Naik S
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1484-93. PubMed ID: 19686410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of a special neutralizing epitope of HEV E2s.
    You M; Xin L; Yang Y; Zhang X; Chen Y; Yu H; Li S; Zhang J; An Z; Luo W; Xia N
    Protein Cell; 2014 Dec; 5(12):950-3. PubMed ID: 25416205
    [No Abstract]   [Full Text] [Related]  

  • 27. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.
    Purcell RH; Nguyen H; Shapiro M; Engle RE; Govindarajan S; Blackwelder WC; Wong DC; Prieels JP; Emerson SU
    Vaccine; 2003 Jun; 21(19-20):2607-15. PubMed ID: 12744897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.
    Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS
    Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis E vaccine].
    Li TC; Takeda N; Miyamura T
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():548-53. PubMed ID: 15453382
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis E virus -- an update.
    Harrison TJ
    Liver; 1999 Jun; 19(3):171-6. PubMed ID: 10395034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E, a vaccine-preventable cause of maternal deaths.
    Labrique AB; Sikder SS; Krain LJ; West KP; Christian P; Rashid M; Nelson KE
    Emerg Infect Dis; 2012 Sep; 18(9):1401-4. PubMed ID: 22931753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of new hepatitis E vaccines.
    Cao Y; Bing Z; Guan S; Zhang Z; Wang X
    Hum Vaccin Immunother; 2018; 14(9):2254-2262. PubMed ID: 29708836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.
    Dong C; Dai X; Meng JH
    Vaccine; 2007 Feb; 25(9):1662-8. PubMed ID: 17156900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation.
    Li Y; Huang X; Zhang Z; Li S; Zhang J; Xia N; Zhao Q
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.
    Yin X; Wang X; Zhang Z; Li Y; Lin Z; Pan H; Gu Y; Li S; Zhang J; Xia N; Zhao Q
    J Pharm Biomed Anal; 2020 Jan; 177():112880. PubMed ID: 31546137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autochthonous hepatitis E in France].
    Buisson Y; Nicand E
    Bull Acad Natl Med; 2006; 190(4-5):973-80. PubMed ID: 17195621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis A and E: not to be forgotten.
    Asghar RJ
    East Mediterr Health J; 2014 Apr; 20(3):212-3. PubMed ID: 24950080
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.
    Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS
    Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral hepatitis vaccination during pregnancy.
    Zhao Y; Jin H; Zhang X; Wang B; Liu P
    Hum Vaccin Immunother; 2016 Apr; 12(4):894-902. PubMed ID: 26833263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis E: an emerging infectious disease in Germany?
    Pischke S; Heim A; Bremer B; Raupach R; Horn-Wichmann R; Ganzenmueller T; Klose B; Goudeva L; Wagner F; Oehme A; Manns MP; Wedemeyer H
    Z Gastroenterol; 2011 Sep; 49(9):1255-7. PubMed ID: 21887661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.